Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01484665 · ClinicalTrials.gov registry record · NA
Evaluating the Effect of a Decision Aid on Shared Decision Making for Prostate Cancer Screening
A NA study, sponsored by University of Minnesota.
- Completed
- Registry status
- NA
- Development phase
- 72
- Enrollment target
NCT01484665 is a NA study that has completed, run by University of Minnesota. The registered enrollment target is 72 participants.
The verdict
NCT01484665, a NA study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- NA
- Development phase
- 72 participants
- Enrollment target
Study Summary
Decision-aids are tools to educate patients on a given topic so that they may better participate in shared-decision making in their health care. Given the complexities associated with PSA testing, many professional organizations have advocated for shared-decision making for PSA testing. However, no consensus exists as to how best educate and involve patients in the shared-decision making process. The goal of this study is to evaluate a pilot program utilizing a simple PSA screening decision-aid presented in two different fashions in a primary care clinic with a large fraction of African-American patients. The investigators will evaluate the effectiveness of this program to educate patients on the risks and benefits of prostate specific antigen (PSA) testing, on their subsequent level of comfort with their decision about whether to receive PSA testing, and on the comfort level of physicians on their patient's decisions regarding PSA testing, and importantly, how well these strategies can be implemented into the daily work-flow of a clinic. If successful, this program may serve as a model for the broader implementation of such strategies across Minnesota and the country.
Interventions
- OTHER PROCASE Decision-Aid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2011-12 |
| Est. Completion | 2012-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01484665
The ClinicalTrials.gov registry entry for NCT01484665 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PROCASE Decision-Aid is the first listed.
NCT01484665 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01484665 about?
NCT01484665 is a clinical study titled "Evaluating the Effect of a Decision Aid on Shared Decision Making for Prostate Cancer Screening". Decision-aids are tools to educate patients on a given topic so that they may better participate in shared-decision making in their health care. Given the complexities associated with PSA testing, many professional organizations have advocated for shared-decision making for PSA testing. However, no ...
What is the current status of trial NCT01484665?
This trial is currently completed. It is a NA study. The enrollment target is 72 participants. The study started on 2011-12. Estimated completion is 2012-06.
What interventions are being tested in trial NCT01484665?
The interventions under investigation include: PROCASE Decision-Aid (OTHER).
Who is sponsoring clinical trial NCT01484665?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.